Surviving biliary sepsis: A retrospective study in a cancer center unveils a 30.3% 90-day mortality rate, with factors like metastatic stage, biliary tract tumor compression, and multi-drug resistant bacteria influencing outcomes. Antibiotic de-escalation emerges as a safe strategy, linked with better survival. Beyond organ dysfunctions, the study emphasizes the impact of cancer stage, bacteria colonization, and performance status on mortality. In the world of biliary sepsis, navigating factors and antibiotic strategies becomes crucial for a favorable 90-day survival.
Journal Article by Thibaud P, Chow-Chine L (…) Mokart D et 12 al. in HPB (Oxford)
Copyright © 2023 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.